Clinical • Enrollment open • Combination therapy
|
EGFR (Epidermal growth factor receptor) • ALK (Anaplastic lymphoma kinase) • ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS)
|
EGFR mutation • ALK mutation • ROS1 mutation
|
Erbitux (cetuximab) • carboplatin • gemcitabine • troculeucel (SNK01)